(Q45863779)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

main subject

hemophilia

0 references

Coagulation factor VIII

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Lopez MF

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Brackmann HH

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Gaillard S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Goudemand J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Humbert J

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

De Moerloose P

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Maass E

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Mauz-Körholz C

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sultan Y

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Stieltjes N

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

431-435

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

Complications of hemophilia A treatment: factor VIII inhibitors

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

Factor VIII and factor IX inhibitors in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

Why do so many haemophilia A patients develop an inhibitor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

Tolerance induction using the Malmö treatment model 1982-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

Immune tolerance induction in haemophiliacs with inhibitor to FVIII: high- or low-dose programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

Inhibitors in congenital haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

Immune tolerance: a synopsis of the international experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

Immune tolerance therapy in paediatric haemophiliacs with factor VIII inhibitors: 14 years follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00354.X

10.1046/J.1365-2516.1999.00354.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10583531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference